Myeloperoxidase: a front-line defender against phagocytosed microorganisms

被引:513
作者
Klebanoff, Seymour J. [1 ]
Kettle, Anthony J. [2 ]
Rosen, Henry [1 ]
Winterbourn, Christine C. [2 ]
Nauseef, William M. [3 ,4 ]
机构
[1] Univ Washington, Dept Med, Seattle, WA USA
[2] Univ Otago Christchurch, Dept Pathol, Ctr Free Rad Res, Christchurch, New Zealand
[3] Univ Iowa, Iowa Inflammat Program, Coralville, IA 52231 USA
[4] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Med, Coralville, IA 52231 USA
基金
美国国家卫生研究院;
关键词
innate immunity; host defense; phagosomes; neutrophils; NITRIC-OXIDE SYNTHASE; CHRONIC GRANULOMATOUS-DISEASE; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; HUMAN NEUTROPHILS EMPLOY; HYDROGEN-PEROXIDE PRODUCTION; GATED PROTON CHANNELS; EARLY HOST-DEFENSE; ALPHA-AMINO-ACIDS; BACTERICIDAL ACTIVITY; HYPOCHLOROUS ACID;
D O I
10.1189/jlb.0712349
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Successful immune defense requires integration of multiple effector systems to match the diverse virulence properties that members of the microbial world might express as they initiate and promote infection. Human neutrophils-the first cellular responders to invading microbes-exert most of their antimicrobial activity in phagosomes, specialized membrane-bound intracellular compartments formed by ingestion of microorganisms. The toxins generated de novo by the phagocyte NADPH oxidase and delivered by fusion of neutrophil granules with nascent phagosomes create conditions that kill and degrade ingested microbes. Antimicrobial activity reflects multiple and complex synergies among the phagosomal contents, and optimal action relies on oxidants generated in the presence of MPO. The absence of life-threatening infectious complications in individuals with MPO deficiency is frequently offered as evidence that the MPO oxidant system is ancillary rather than essential for neutrophil-mediated antimicrobial activity. However, that argument fails to consider observations from humans and KO mice that demonstrate that microbial killing by MPO-deficient cells is less efficient than that of normal neutrophils. We present evidence in support of MPO as a major arm of oxidative killing by neutrophils and propose that the essential contribution of MPO to normal innate host defense is manifest only when exposure to pathogens overwhelms the capacity of other host defense mechanisms. J. Leukoc. Biol. 93: 185-198; 2013.
引用
收藏
页码:185 / 198
页数:14
相关论文
共 230 条
[1]   Nitric oxide is a physiological substrate for mammalian peroxidases [J].
Abu-Soud, HM ;
Hazen, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) :37524-37532
[2]  
Agner K, 1943, ADV ENZYMOL REL S BI, V3, P137
[3]  
Agner K., 1941, Acta Chemica Scandanavia, A, V2, P1
[4]   LISTERICIDAL ACTIVITY OF HUMAN NEUTROPHIL CATHEPSIN-G [J].
ALFORD, CE ;
AMARAL, E ;
CAMPBELL, PA .
JOURNAL OF GENERAL MICROBIOLOGY, 1990, 136 :997-1000
[5]   Reduced-oxidized difference spectral analysis and chemiluminescence-based Scatchard analysis demonstrate selective binding of myeloperoxidase to microbes [J].
Allen, Robert C. ;
Stephens, Jackson T., Jr. .
LUMINESCENCE, 2011, 26 (03) :208-213
[6]   Myeloperoxidase Selectively Binds and Selectively Kills Microbes [J].
Allen, Robert C. ;
Stephens, Jackson T., Jr. .
INFECTION AND IMMUNITY, 2011, 79 (01) :474-485
[7]   Nitric oxide in Tanzanian children with malaria: Inverse relationship between malaria severity and nitric oxide production nitric oxide synthase type 2 expression [J].
Anstey, NM ;
Weinberg, JB ;
Hassanali, M ;
Mwaikambo, ED ;
Manyenga, D ;
Misukonis, MA ;
Arnelle, DR ;
Hollis, D ;
McDonald, MI ;
Granger, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :557-567
[8]  
Aratani Y, 2004, JPN J INFECT DIS, V57, pS15
[9]  
Aratani Y, 2002, MED MYCOL, V40, P557, DOI 10.1080/mmy.40.6.557.563
[10]   Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans [J].
Aratani, Y ;
Kura, F ;
Watanabe, H ;
Akagawa, H ;
Takano, Y ;
Suzuki, K ;
Dinauer, MC ;
Maeda, N ;
Koyama, H .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (12) :1833-1837